Stephen H. Willard

About

Stephen H. Willard is a U.S. biotechnology executive and lawyer who became Chief Executive Officer of Longeveron in February 2026. Public company and government sources describe more than 30 years of biotech and pharmaceutical leadership, including CEO roles at ICaPath, NRx Pharmaceuticals, Cellphire, and Flamel Technologies, as well as service on the National Science Board. His public profile is that of an operating executive and science-policy participant rather than a capital allocator.

Areas of interest